뇌체세포 산소 농도계 : 시장 점유율 분석, 산업 동향 및 통계, 성장 예측(2024-2029년)

The Cerebral Somatic Oximeters Market size is expected to grow from USD 191.21 million in 2024 to USD 243.51 million by 2029, at a CAGR of 6.23% during the forecast period (2024-2029).

Key Highlights

• The cerebral somatic oximeters market was significantly affected by the COVID-19 pandemic. Since the onset of the pandemic, elective procedures were been postponed or canceled in many countries, along with disruptions in the supply chain of medical devices, especially in developing nations. For instance, an article published in the Brazilian Journal of Cardiovascular Surgery in May 2022 stated that the hospital staff at Main University Hospital, Egypt, were instructed to postpone new admissions from cardiac surgery outpatient clinics and to perform surgeries exclusively for patients currently admitted and emergencies during the pandemic. However, the market started to recover as non-essential medical procedures resumed gradually over the last two years around the world.
• The market for cerebral somatic oximeters is expected to witness healthy growth over the forecast period. The increase is majorly attributed to the rising incidence of neurological diseases and the growing adoption of cerebral oximeters in developed economies such as North America and Europe.
• According to an article published in the National Center for Biotechnology Information (NCBI) in April 2022, hypoxic-ischemic encephalopathy (HIE) is reported in 1 to 6 per 1000 live births in developed countries and 26 per 1000 live births in developing countries. The high burden of such neurological diseases propels the demand for cerebral somatic oximeters to detect the oxygen levels in the brain, thereby boosting market growth.
• In addition, cerebral oximetry is used routinely in some neonatal intensive care units (NICUs). For instance, as per an article published in Frontiers in Pediatrics Journal in April 2022, cerebral oximetry is utilized in the context of cardiac surgery and is used almost universally as a clinical routine in the perioperative care of newborn infants with congenital heart disease and neonatology. As per the article, currently, a clinical trial is ongoing to assess the importance of cerebral oximetry in severe brain injury in the neonatal department. The rising research studies are expected to propel the utility of cerebral somatic oximeters in the detection of oxygen levels of various brain and cardiac diseases during the forecast period.
• Furthermore, the strategic initiatives by market players, such as technological advancement leading to product approvals and launches, along with partnerships, are also contributing to the market growth during the forecast period. For instance, in December 2021, Medtronic PLC received Food Drug Administration (FDA) 510(k) approval for its INVOS 7100 cerebral/somatic oximetry system for pediatric indications. The INVOS system helps pediatric clinicians make time-sensitive decisions regarding ventilation, hemodynamic management, and resuscitation for neonates, premature infants, children, and other patients treated by them. Therefore, the launch of the technologically advanced cerebral oximeters for the pediatric population is expected to widen its customer base and add growth to the cerebral somatic oximeters market during the forecast period.
• Therefore, owing to the aforementioned factors, such as the high burden of neurological diseases and technologically advanced product approvals, the cerebral somatic oximeters market is anticipated to witness growth over the analysis period. However, the high cost of the device due to the expensive sensors used in the cerebral oximeters is estimated to restrain the market growth.

Cerebral Somatic Oximeters Market Trends

Cardiac Surgery is Expected to Hold a Significant Market Share Over The Forecast Period

• Cardiovascular surgeries, by application, are expected to hold a significant market share in the cerebral oximetry market during the forecast period. The increased demand for these devices in aortic surgery, arrhythmia surgery, myomectomy, and coronary artery bypass graft (CABG) procedures can be attributed to their ability to minimize the risk of complications and reduce anastomotic leaks.
• The major factors attributing to the growth of cerebral oximeters are a deskbound lifestyle lacking physical activity, lack of proper diet, anxiety, and stress resulting in chronic diseases, thereby leading to the prevalence of multiple cardiovascular diseases (CVD). For instance, according to the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics, 2022 update, angina was reported in 1.5% of the adult population aged 18 and over in the United States.
• Also, according to the Australian Bureau of Statistics, March 2022 update, the prevalence of heart disease in Australia was 4.0%, which represented 1.0 million people in 2021. Heart diseases such as angina, heart attack, stroke, and other cardiovascular diseases were more common in males than females (4.9% compared to 3.1%). Thus, the high burden of cardiovascular diseases worldwide is expected to lead to a high number of CABG procedures worldwide, which is expected to propel the segment growth during the forecast period.
• Furthermore, a research article published in PLOS One Journal in December 2021 stated that the cerebral oximeter is frequently used to detect changes in cerebral oxygen saturation and cerebral ischemia during cardiac surgery. As per the same source, between 25% and 80% of patients who underwent major heart surgery experienced postoperative neurocognitive impairments (POND) during the course of the study. During major cardiac surgery, the use of a cerebral oximeter is crucial to predicting the onset of POND. The study also suggested that increased cerebral oximeter levels during cardiac surgery may also be a risk factor for POND. Thus, the high utility of cerebral somatic oximeters in research studies is expected to propel its demand during cardiac surgery, which is projected to augment segment growth.
• Therefore, the high burden of cardiac surgery performed worldwide, along with the use of cerebral oximeters in cardiac surgery, is significantly impacting the growth of the segment during the forecast period.

North America is Expected to Hold a Significant Market Share Over The Forecast Period

• North America is expected to hold a significant market share owing to factors such as the rising incidence of neurological diseases, the growing geriatric population, better healthcare infrastructure, and the strong presence of industry players in the region.
• The data updated by Cedars-Sinai in January 2022 reported that coronary artery bypass graft surgery (CABG), also known as coronary artery bypass or bypass surgery, is the most common heart surgery and more than 300,000 people have successful bypass surgery in the United States each year. Thus, the high burden of CABG procedures in the United States is expected to propel the high utility of cerebral somatic oximeters and also create opportunities for developing technologically advanced products, propelling the growth of the segment.
• Furthermore, according to the Alzheimer's Association, the number of Americans living with Alzheimer's is growing rapidly. The data from alzheimers.org suggested that in 2021, in the United States, an estimated 6.2 million Americans aged 65 and older were living with Alzheimer-related dementia. Thus, the high burden of neurological diseases in the region is expected to propel the growth of the cerebral somatic oximeters used for the detection of oxygen levels of the brain, which is projected to propel the market growth.
• In addition, as per the National Institute of Health (NIH) Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC), 2022 update, the research spending on cerebral palsy was USD 30 million in 2021 and estimated to be USD 32 million in 2022 in the United States. Cerebral oximeters are widely used in these diseases for routine oxygen level detection. The high spending on the research of diseases is expected to create opportunities for developing innovative cerebral somatic oximeters, thereby boosting market growth in the region during the forecast period.
• Thus, owing to all the above-mentioned factors, the market studied is expected to witness high growth in the region.

Cerebral Somatic Oximeters Industry Overview

The cerebral somatic oximeters market is moderately consolidated in nature due to the presence of few market players. The major players have established themselves in specific segments of the market. Furthermore, the companies are competing in emerging regions with global players and with established local players. Key players are developing and launching novel products and technologies to compete with existing products, while others are acquiring and partnering with other companies trending in the market. Some key players are Masimo, Medtronic Plc, Edwards Lifesciences, Nonin Medical, Inc., ISS Inc., GE Healthcare Inc., Koninklijke Philips N.V., and Mespere LifeSciences.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Incrreasing Adoption of the Cerebral Oximeters
  • 4.2.2 Rising Incidence of Neurological Diseases
• 4.3 Market Restraints
  • 4.3.1 High Cost of the Device
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD)

• 5.1 By Type
  • 5.1.1 Dual Emitter and Dual Detector
  • 5.1.2 Single Emitter and Dual Detector
  • 5.1.3 Other Types
• 5.2 By Application
  • 5.2.1 Cardiac Surgery
  • 5.2.2 Vascular Surgery
  • 5.2.3 Other Applications
• 5.3 By Patient Type
  • 5.3.1 Pediatrics
  • 5.3.2 Adults
• 5.4 By End-User
  • 5.4.1 Hospitals and Clinics
  • 5.4.2 Ambulatory Surgical Centers
  • 5.4.3 Other End-Users
• 5.5 Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Medtronic PLC
  • 6.1.2 Nonin Medical Inc.
  • 6.1.3 Edwards Lifesciences
  • 6.1.4 ISS Inc.
  • 6.1.5 Masimo
  • 6.1.6 GE Healthcare Inc.
  • 6.1.7 Koninklijke Philips N.V.
  • 6.1.8 Mespere LifeSciences

7 MARKET OPPORTUNITIES AND FUTURE TRENDS